Individual and combined effects of DNA methylation and copy number alterations on miRNA expression in breast tumors
暂无分享,去创建一个
Sampsa Hautaniemi | Riku Louhimo | Olga G Troyanskaya | Vessela N Kristensen | Qian Zhu | Jens Overgaard | Nizar Touleimat | Jan Alsner | Ole Christian Lingjærde | Thomas Fleischer | O. Troyanskaya | A. Børresen-Dale | S. Leivonen | V. Kristensen | M. R. Aure | K. Sahlberg | O. Lingjærde | S. Hautaniemi | Qian Zhu | J. Overgaard | J. Alsner | R. Louhimo | J. Tost | Thomas Fleischer | N. Touleimat | T. Tramm | M. Perälä | F. Busato | Anne-Lise Børresen-Dale | Miriam Ragle Aure | Suvi-Katri Leivonen | Trine Tramm | Grethe I Grenaker Alnæs | Merja Perälä | Florence Busato | Jörg Tost | Kristine Kleivi Sahlberg | G. G. Alnæs | T. Fleischer
[1] Andrea Sottoriva,et al. The shaping and functional consequences of the microRNA landscape in breast cancer , 2013, Nature.
[2] Paul Bertone,et al. Systematic comparison of microarray profiling, real-time PCR, and next-generation sequencing technologies for measuring differential microRNA expression. , 2010, RNA.
[3] Steven J. M. Jones,et al. Circos: an information aesthetic for comparative genomics. , 2009, Genome research.
[4] F. Slack,et al. The let-7 family of microRNAs. , 2008, Trends in cell biology.
[5] F. Yu,et al. MicroRNA 34c Gene Down-regulation via DNA Methylation Promotes Self-renewal and Epithelial-Mesenchymal Transition in Breast Tumor-initiating Cells* , 2011, The Journal of Biological Chemistry.
[6] Reuven Agami,et al. miR-148 targets human DNMT3b protein coding region. , 2008, RNA.
[7] T. Furuya,et al. DNA copy number aberrations associated with the clinicopathological features of colorectal cancers: Identification of genomic biomarkers by array-based comparative genomic hybridization. , 2011, Oncology reports.
[8] F. Jones,et al. Jumonji/ARID1 B (JARID1B) Protein Promotes Breast Tumor Cell Cycle Progression through Epigenetic Repression of MicroRNA let-7e* , 2011, The Journal of Biological Chemistry.
[9] A. Long,et al. A human cell line from a pleural effusion derived from a breast carcinoma. , 1973, Journal of the National Cancer Institute.
[10] C. Benz,et al. Coordinate Suppression of ERBB2 and ERBB3 by Enforced Expression of Micro-RNA miR-125a or miR-125b* , 2007, Journal of Biological Chemistry.
[11] Yan Wang,et al. EGFR modulates microRNA maturation in response to hypoxia through phosphorylation of AGO2 , 2013, Nature.
[12] S. Clark,et al. Mapping the regulatory sequences controlling 93 breast cancer-associated miRNA genes leads to the identification of two functional promoters of the Hsa-mir-200b cluster, methylation of which is associated with metastasis or hormone receptor status in advanced breast cancer , 2012, Oncogene.
[13] M. Kurosumi,et al. Isolation and characterization of a new human breast cancer cell line, KPL-4, expressing the Erb B family receptors and interleukin-6 , 1999, British Journal of Cancer.
[14] C. Croce,et al. Human microRNA genes are frequently located at fragile sites and genomic regions involved in cancers. , 2004, Proceedings of the National Academy of Sciences of the United States of America.
[15] Liang Chen,et al. Role of Deregulated microRNAs in Breast Cancer Progression Using FFPE Tissue , 2013, PloS one.
[16] Wolfgang Huber,et al. Analysis of cell-based RNAi screens , 2006, Genome Biology.
[17] F. Staedtler,et al. Integrated Epigenetics of Human Breast Cancer: Synoptic Investigation of Targeted Genes, MicroRNAs and Proteins upon Demethylation Treatment , 2011, PloS one.
[18] Chiara Romualdi,et al. miR148b is a major coordinator of breast cancer progression in a relapse‐associated microRNA signature by targeting ITGA5, ROCK1, PIK3CA, NRAS, and CSF1 , 2013, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[19] Ming Yao,et al. Gain of miR-151 on chromosome 8q24.3 facilitates tumour cell migration and spreading through downregulating RhoGDIA , 2010, Nature Cell Biology.
[20] Simen Myhre,et al. Influence of DNA copy number and mRNA levels on the expression of breast cancer related proteins , 2013, Molecular oncology.
[21] Axel Benner,et al. Circulating microRNAs in plasma as early detection markers for breast cancer , 2013, International journal of cancer.
[22] H. Trompeter,et al. Role of DNA methylation in miR-200c/141 cluster silencing in invasive breast cancer cells , 2010, BMC Research Notes.
[23] M. Esteller,et al. Validation of a DNA methylation microarray for 450,000 CpG sites in the human genome , 2011, Epigenetics.
[24] Stephen Safe,et al. IDENTIFICATION OF ONCOGENIC MicroRNA-17-92/ZBTB4/SPECIFICITY PROTEIN AXIS IN BREAST CANCER , 2011, Oncogene.
[25] Ivo G Gut,et al. DNA methylation analysis by pyrosequencing , 2007, Nature Protocols.
[26] H. Horvitz,et al. MicroRNA expression profiles classify human cancers , 2005, Nature.
[27] Jun Luo,et al. MicroRNA let-7c Is Downregulated in Prostate Cancer and Suppresses Prostate Cancer Growth , 2012, PloS one.
[28] Martha R. Stampfer,et al. miRNA Gene Promoters Are Frequent Targets of Aberrant DNA Methylation in Human Breast Cancer , 2013, PloS one.
[29] J. Tost,et al. Complete pipeline for Infinium(®) Human Methylation 450K BeadChip data processing using subset quantile normalization for accurate DNA methylation estimation. , 2012, Epigenomics.
[30] Y. Yatabe,et al. Reduced Expression of the let-7 MicroRNAs in Human Lung Cancers in Association with Shortened Postoperative Survival , 2004, Cancer Research.
[31] Tom H. Pringle,et al. The human genome browser at UCSC. , 2002, Genome research.
[32] C. Croce,et al. MicroRNA gene expression deregulation in human breast cancer. , 2005, Cancer research.
[33] H. Soule,et al. Estrogen receptor in a human cell line (MCF-7) from breast carcinoma. , 1973, The Journal of biological chemistry.
[34] G Kvalheim,et al. Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics. , 2001, Clinical cancer research : an official journal of the American Association for Cancer Research.
[35] Daxi Sun,et al. Mutant p53 Cooperates with ETS and Selectively Up-regulates Human MDR1 Not MRP1* , 2001, The Journal of Biological Chemistry.
[36] Christoph Flamm,et al. The expansion of the metazoan microRNA repertoire , 2006, BMC Genomics.
[37] J. Steitz,et al. miR-29 and miR-30 regulate B-Myb expression during cellular senescence , 2010, Proceedings of the National Academy of Sciences.
[38] Rudolf Jaenisch,et al. Targeted Deletion Reveals Essential and Overlapping Functions of the miR-17∼92 Family of miRNA Clusters , 2008, Cell.
[39] Hiroyuki Tagawa,et al. Aberrant overexpression of microRNAs activate AKT signaling via down-regulation of tumor suppressors in natural killer-cell lymphoma/leukemia. , 2009, Blood.
[40] Peter A. Jones,et al. Cancer epigenetics: modifications, screening, and therapy. , 2008, Annual review of medicine.
[41] S. Bortoluzzi,et al. Impact of Host Genes and Strand Selection on miRNA and miRNA* Expression , 2011, PloS one.
[42] U. Lehmann,et al. Epigenetic inactivation of microRNA gene hsa‐mir‐9‐1 in human breast cancer , 2008, The Journal of pathology.
[43] T. Sørlie,et al. Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms , 2006, BMC Genomics.
[44] Israel Steinfeld,et al. miRNA-mRNA Integrated Analysis Reveals Roles for miRNAs in Primary Breast Tumors , 2011, PloS one.
[45] C. Croce,et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[46] Qiong Shao,et al. MicroRNA miR-21 overexpression in human breast cancer is associated with advanced clinical stage, lymph node metastasis and patient poor prognosis. , 2008, RNA.
[47] C. Burge,et al. Most mammalian mRNAs are conserved targets of microRNAs. , 2008, Genome research.
[48] O. Rennert,et al. Genome-wide DNA methylation profiling reveals novel epigenetically regulated genes and non-coding RNAs in human testicular cancer , 2010, British Journal of Cancer.
[49] Y. Benjamini,et al. Controlling the false discovery rate: a practical and powerful approach to multiple testing , 1995 .
[50] A. Frigessi,et al. In Silico Ascription of Gene Expression Differences to Tumor and Stromal Cells in a Model to Study Impact on Breast Cancer Outcome , 2010, PloS one.
[51] Qiang Zhou,et al. TSA Suppresses miR-106b-93-25 Cluster Expression through Downregulation of MYC and Inhibits Proliferation and Induces Apoptosis in Human EMC , 2012, PloS one.
[52] Vlad I. Morariu,et al. Expression , 2015, Principles of Molecular Virology.
[53] L. Zhao,et al. Integrative Analysis in Oral Squamous Cell Carcinoma Reveals DNA Copy Number–Associated miRNAs Dysregulating Target Genes , 2012, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.
[54] Anthony Fyles,et al. MicroRNA-301 mediates proliferation and invasion in human breast cancer. , 2011, Cancer research.
[55] A. Børresen-Dale,et al. Protein lysate microarray analysis to identify microRNAs regulating estrogen receptor signaling in breast cancer cell lines , 2009, Oncogene.
[56] David T. W. Jones,et al. Signatures of mutational processes in human cancer , 2013, Nature.
[57] R Core Team,et al. R: A language and environment for statistical computing. , 2014 .
[58] Hiromu Suzuki,et al. DNA methylation and microRNA dysregulation in cancer , 2012, Molecular oncology.
[59] W. Gerald,et al. Endogenous human microRNAs that suppress breast cancer metastasis , 2008, Nature.
[60] Therese Sørlie,et al. Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer , 2007, Molecular oncology.
[61] Li Li,et al. High‐resolution genomic and expression analyses of copy number alterations in breast tumors , 2008, Genes, chromosomes & cancer.
[62] Olli Kallioniemi,et al. High‐throughput screens identify microRNAs essential for HER2 positive breast cancer cell growth , 2014, Molecular oncology.
[63] Wenlin Huang,et al. miR-125b is methylated and functions as a tumor suppressor by regulating the ETS1 proto-oncogene in human invasive breast cancer. , 2011, Cancer research.
[64] Sampsa Hautaniemi,et al. CNAmet: an R package for integrating copy number, methylation and expression data , 2011, Bioinform..
[65] C. Croce. Causes and consequences of microRNA dysregulation in cancer , 2009, Nature Reviews Genetics.
[66] C. Burge,et al. Conserved Seed Pairing, Often Flanked by Adenosines, Indicates that Thousands of Human Genes are MicroRNA Targets , 2005, Cell.
[67] Manran Liu,et al. Antagonism of miR-21 Reverses Epithelial-Mesenchymal Transition and Cancer Stem Cell Phenotype through AKT/ERK1/2 Inactivation by Targeting PTEN , 2012, PloS one.
[68] F. Yu,et al. Mir-30 reduction maintains self-renewal and inhibits apoptosis in breast tumor-initiating cells , 2010, Oncogene.
[69] Vinay Varadan,et al. DNA methylation patterns in luminal breast cancers differ from non‐luminal subtypes and can identify relapse risk independent of other clinical variables , 2011, Molecular oncology.
[70] Jorma Isola,et al. Characterization of a novel cell line established from a patient with Herceptin-resistant breast cancer. , 2004, Molecular cancer therapeutics.
[71] Sheng Tan,et al. Pivotal role of reduced let-7g expression in breast cancer invasion and metastasis. , 2011, Cancer research.
[72] Kenneth M. Yamada,et al. PTEN Interactions with Focal Adhesion Kinase and Suppression of the Extracellular Matrix-dependent Phosphatidylinositol 3-Kinase/Akt Cell Survival Pathway* , 1999, The Journal of Biological Chemistry.
[73] V. Beneš,et al. Widespread estrogen-dependent repression of micrornas involved in breast tumor cell growth. , 2009, Cancer research.
[74] J. Inazawa,et al. Tumor‐suppressive microRNA silenced by tumor‐specific DNA hypermethylation in cancer cells , 2012, Cancer science.
[75] Wei Zhou,et al. Implication of snoRNA U50 in human breast cancer. , 2009, Journal of genetics and genomics = Yi chuan xue bao.
[76] Volker Hovestadt,et al. Molecular and Cellular Pathobiology MicroRNA Sequence and Expression Analysis in Breast Tumors by Deep Sequencing , 2011 .
[77] Elmar Bucher,et al. Genome‐wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients , 2008, Genes, chromosomes & cancer.
[78] A. Børresen-Dale,et al. Copynumber: Efficient algorithms for single- and multi-track copy number segmentation , 2012, BMC Genomics.
[79] Jae Hoon Kim,et al. Analysis of chromosomal changes in serous ovarian carcinoma using high‐resolution array comparative genomic hybridization: Potential predictive markers of chemoresistant disease , 2007, Genes, chromosomes & cancer.
[80] Barbara J. Trask,et al. Array Comparative Genomic Hybridization Analysis of Genomic Alterations in Breast Cancer Subtypes , 2004, Cancer Research.
[81] N. Biglia,et al. Effects of Oestrogen on MicroRNA Expression in Hormone-Responsive Breast Cancer Cells , 2012, Hormones and Cancer.
[82] Grace X. Y. Zheng,et al. MicroRNAs can generate thresholds in target gene expression , 2011, Nature Genetics.
[83] V. Kristensen,et al. Expression of BMI-1 and Mel-18 in breast tissue - a diagnostic marker in patients with breast cancer , 2010, BMC Cancer.
[84] Stijn van Dongen,et al. miRBase: microRNA sequences, targets and gene nomenclature , 2005, Nucleic Acids Res..
[85] Z. Yakhini,et al. Deregulation of cancer-related miRNAs is a common event in both benign and malignant human breast tumors. , 2014, Carcinogenesis.
[86] B. Rasmussen,et al. Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial , 1999, The Lancet.
[87] S. Ropero,et al. A microRNA DNA methylation signature for human cancer metastasis , 2008, Proceedings of the National Academy of Sciences.
[88] K. Zedeler,et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. , 1997, The New England journal of medicine.
[89] Kathryn A. O’Donnell,et al. c-Myc-regulated microRNAs modulate E2F1 expression , 2005, Nature.
[90] Zhen Su,et al. Integrative genomic analyses reveal clinically relevant long non-coding RNA in human cancer , 2013 .
[91] Leonard D. Goldstein,et al. MicroRNA expression profiling of human breast cancer identifies new markers of tumor subtype , 2007, Genome Biology.
[92] J. Weiler,et al. Regulating the regulators: mechanisms controlling the maturation of microRNAs. , 2009, Trends in biotechnology.
[93] Robert Tibshirani,et al. Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene‐expression subtypes of breast cancer , 2006, Genes, chromosomes & cancer.